Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer

per Hirsh, Vera
Publicat 2010

Review of the treatment of metastatic non small cell lung carcinoma: A practical approach

per Hirsh, Vera
Publicat 2011

Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer

per Hirsh, Vera
Publicat 2012

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

per Hirsh, Vera
Publicat 2014

Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?

per Hirsh, Vera
Publicat 2013

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

per Hirsh, Vera
Publicat 2014

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

per Hirsh, Vera
Publicat a Front Oncol (2015)

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib

per Hirsh, Vera
Publicat a BioDrugs (2015)

New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib

per Hirsh, Vera
Publicat a Onco Targets Ther (2017)

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

per Hirsh, Vera
Publicat a Ther Adv Med Oncol (2018)

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs

per Melosky, Barbara, Hirsh, Vera
Publicat 2014

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

per Blais, Normand, Hirsh, Vera
Publicat 2014

Optimal sequencing strategies in the treatment of EGFR mutation–positive non–small cell lung cancer: Clinical benefits and cost-effectiveness

per Hirsh, Vera, Singh, Jaspal
Publicat a Am J Health Syst Pharm (2020)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

per Morin-Ben Abdallah, Sami, Hirsh, Vera
Publicat a Front Oncol (2017)

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemot...

per Hirsh, Vera, Glaspy, John, Mainwaring, Paul, Manegold, Christian, Ramlau, Rodryg, Eid, Joseph E
Publicat 2007

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

per Ascierto, Paolo A., Daniele, Bruno, Hammers, Hans, Hirsh, Vera, Kim, Joseph, Licitra, Lisa, Nanda, Rita, Pignata, Sandro
Publicat a J Transl Med (2017)

Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer

per Melosky, Barbara, Juergens, Rosalyn, Hirsh, Vera, McLeod, Deanna, Leighl, Natasha, Tsao, Ming‐Sound, Card, Paul B., Chu, Quincy
Publicat a Oncologist (2019)

Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients wit...

per Buttigliero, Consuelo, Shepherd, Frances A., Barlesi, Fabrice, Schwartz, Brian, Orlov, Sergey, Favaretto, Adolfo G., Santoro, Armando, Hirsh, Vera, Ramlau, Rodryg, Blackler, Adele R., Roder, Joanna, Spigel, David, Novello, Silvia, Akerley, Wallace, Scagliotti, Giorgio V.
Publicat a Oncologist (2018)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015

per Ascierto, Paolo A., Ascierto, Maria Libera, Formenti, Silvia, Gnjatic, Sacha, Hammers, Hans, Hirsh, Vera, Kiessling, Rolf, Melero, Ignacio, Nanda, Rita, Pawelec, Graham, Pignata, Sandro, Romero, Pedro, Speiser, Daniel E., Fox, Bernard A., Marincola, Francesco M.
Publicat a J Immunother Cancer (2016)

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

per Wu, Yi-Long, Sequist, Lecia V, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O'Byrne, Kenneth, Hirsh, Vera, Gibson, Neil, Massey, Dan, Kim, Miyoung, Yang, James Chih-Hsin
Publicat a Br J Cancer (2017)